Inhibition of ULK1/2 and KRAS(G12C) controls tumor growth in preclinical models of lung cancer.
Ghazi PC, O'Toole KT, Srinivas Boggaram S, Scherzer MT, Silvis MR, Zhang Y, Bogdan M, Smith BD, Lozano G, Flynn DL, et al. Elife. 2024 Aug 30; 13. Epub 2024 Aug 30.